Literature DB >> 8681733

[Treatment of radiotherapy-induced gastroparesis with erythromycin].

A Sturm1, M von der Ohe, U Rosien, H Goebell, P Layer.   

Abstract

HISTORY: A 75-year-old woman who had undergone a hysterectomy with adnexectomy followed by radiotherapy for endometrial carcinoma complained of postprandial nausea with vomiting after eating solid foods and of cramp-like abdominal pain, but her appetite was good. She had lost 25 kg in weight over 13 months. EXAMINATION: Physical examination, laboratory tests, radiology and gastroscopy were unremarkable. Gastric scintigraphy showed abnormally prolonged emptying. TREATMENT AND COURSE: Nausea and vomiting stopped at once after erythromycin (a motilin agonist) had been administered. It was at first given intravenously after meals (50 mg three times daily for 5 days), then orally for 10 weeks (250 mg three times daily before meals). Subsequent examination revealed normal gastric emptying. The symptoms did not recur after erythromycin had been discontinued.
CONCLUSION: Erythromycin is an effective drug against gastroparesis caused by radiotherapy, because it acts even when the enteric nerves are damaged.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681733     DOI: 10.1055/s-2007-1023931

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Radiation induced gastroparesis-case report and literature review.

Authors:  Pierre Annede; Caroline Prieux-Klotz; Thomas Dubergé; Cyrus Chargari; Olivier Gisserot; Jean-Pierre de Jaureguiberry
Journal:  J Gastrointest Oncol       Date:  2017-08

2.  Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill.

Authors:  Marc A Ritz; Marianne J Chapman; Robert J Fraser; Mark E Finnis; Ross N Butler; Patricia Cmielewski; Geoffrey P Davidson; Deborah Rea
Journal:  Intensive Care Med       Date:  2005-06-07       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.